Huons has been recognized by the government for its achievements in open innovation at a domestic technology transfer and investment exchange event in the biohealth sector.


Huons received the Minister of Health and Welfare Award for contributions to the commercialization of the biohealth industry sector at the 24th Interbiz Bio Partnering & Investment Forum 2026 held at Phoenix Island, Jeju, on the 1st. The photo shows Kyungmi Park, Executive Vice President of Research and Development at Huons (center), presenting the award to Jungjin Kim, Chairman of the Korea New Drug Development Association (left), and Gangsub Im, Manager of the Pharmaceutical Bio Industry Division at the Ministry of Health and Welfare (right). Photo by Huons

Huons received the Minister of Health and Welfare Award for contributions to the commercialization of the biohealth industry sector at the 24th Interbiz Bio Partnering & Investment Forum 2026 held at Phoenix Island, Jeju, on the 1st. The photo shows Kyungmi Park, Executive Vice President of Research and Development at Huons (center), presenting the award to Jungjin Kim, Chairman of the Korea New Drug Development Association (left), and Gangsub Im, Manager of the Pharmaceutical Bio Industry Division at the Ministry of Health and Welfare (right). Photo by Huons

View original image

On July 1, at the opening ceremony of the "24th Interbiz Bio Partnering & Investment Forum 2026" held at Phoenix Island, Jeju, Huons announced on July 2 that it received the Minister of Health and Welfare Award for outstanding achievement in the commercialization of the biohealth industry sector.


The award for outstanding achievement in commercialization is presented to companies and individuals who have made substantial contributions to the diffusion of technology and the promotion of commercialization through online and offline collaborative environments. Huons was recognized for its leadership in collaboration among industry, academia, research institutes, ventures, and startups by participating in the Interbiz Forum over the years. In particular, the company received high marks for its concrete accomplishments in technology commercialization, such as proactively licensing in promising pipelines and making equity investments in venture companies.


Kyungmi Park, Vice President of Research and Development at Huons, stated, "This award is the result of Huons' open innovation efforts to establish a sustainable collaboration model with industry, academia, and research institutes. We will continue to strengthen our network with promising domestic and international partners to drive joint growth across the healthcare industry and enhance global competitiveness."



Meanwhile, the "24th Interbiz Bio Partnering & Investment Forum 2026" is an event aimed at promoting mutual cooperation and global expansion among key R&D stakeholders in the pharmaceutical and biohealth sectors, including industry, academia, research institutes, ventures, and startups. Sixteen organizations, including the Korea New Drug Development Association, are co-hosting the event.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing